Publications by authors named "Noemi Muszbek"

Claim this Profile
O
Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care.
Neil Hawkins, Noemi Muszbek, Rachel Evans, Linda McNamara, Trefor Jones

J Comp Eff Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility analysis of mogamulizumab in advanced mycosis fungoides and Sézary syndrome cutaneous T-cell lymphoma.
Noemi Muszbek, Edit Remak, Qian Xin, Linda McNamara, Trefor Jones

J Comp Eff Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjusting for treatment crossover in the MAVORIC trial: survival in advanced mycosis fungoides and Sézary syndrome.
Neil Hawkins, Noemi Muszbek, Rachel Evans, Pascale Dequen-O'Byrne, Trefor Jones

J Comp Eff Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC).
Noemi Muszbek, Rachel Evans, Edit Remak, Victoria K Brennan, Fabien Colaone

Expert Rev Pharmacoecon Outcomes Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility analysis of selective internal radiation therapy with Y-90 resin microspheres in hepatocellular carcinoma.
Noemi Muszbek, Edit Remak, Rachel Evans, Victoria K Brennan, Fabien Colaone

Future Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Sarilumab Added to Methotrexate in the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors.
Noemi Muszbek, Clare Proudfoot, Marie Fournier, Chieh-I Chen, Andreas Kuznik

J Manag Care Spec Pharm· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs.
Noemi Muszbek, Clare Proudfoot, Marie Fournier, Chieh-I Chen, Andreas Kuznik

Adv Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective.
Rebekah H Borse, Chloe Brown, Noemi Muszbek, Mohammad Ashraf Chaudhary, Sumesh Kachroo

Rheumatol Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative healthcare-associated costs of methicillin-resistant Staphylococcus aureus bacteraemia-infective endocarditis treated with either daptomycin or vancomycin.
Chantelle Browne, Noemi Muszbek, Ruth Chapman, Kevin Marsh, Ian M Gould

Int J Antimicrob Agents· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cost-effectiveness of Pixantrone for Third/Fourth-line Treatment of Aggressive Non-Hodgkin's Lymphoma.
Noemi Muszbek, Ananth Kadambi, Tereza Lanitis, Anthony J Hatswell, Dilip Patel

Clin Ther· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using daptomycin in hospitalised patients with cSSTI caused by Staphylococcus aureus has an impact on costs.
Noemi Muszbek, Ruth Chapman, Chantelle Browne, Kevin Marsh, Ian M Gould

Chemotherapy· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of parametric survival analysis for health-economic applications.
K Jack Ishak, Noemi Kreif, Agnes Benedict, Noemi Muszbek

Pharmacoeconomics· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling survival in hepatocellular carcinoma.
Noemi Muszbek, Noemi Kreif, Adriana Valderrama, Agnes Benedict, Jack Ishak

Curr Med Res Opin· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of sorafenib in unresectable hepatocellular carcinoma.
Brian I Carr, Stuart Carroll, Noemi Muszbek, Kathleen Gondek

J Gastroenterol Hepatol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of sorafenib in the treatment of hepatocellular carcinoma in Canada.
Noemi Muszbek, Sonalee Shah, Stuart Carroll, Heather McDonald, Peter Dale

Curr Med Res Opin· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public health value of fixed-dose combinations in hypertension.
Luis M Ruilope, Michel Burnier, Noemi Muszbek, Ruth E Brown, Abdulkadir Keskinaslan

Blood Press Suppl· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis.
Andrew J Palmer, William J Valentine, Joshua A Ray, Stephane Roze, Noemi Muszbek

Eur J Health Econ· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does therapeutic reference pricing always result in cost-containment? The Hungarian evidence.
Zoltán Kaló, Noémi Muszbek, József Bodrogi, Judit Bidló

Health Policy· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Economic evaluation of population-based mass screening for the early detection of cancer: a systematic review].
Noémi Muszbek, Tamás Koncz, Piroska V Hajdú, Róza Adány

Magy Onkol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis